New Haven Clinical Research Unit

New Haven, Connecticut 06511

0 studies enrolling now · 63 studies all time

What they study most

Atopic Dermatitis, Biological Availability, Chronic Rhinosinusitis With Nasal Polyps, Dermatitis, Atopic, Healthy, Healthy Participant, Healthy Participants, Healthy Subjects, Healthy Volunteer Study, Healthy Volunteers, Hemophilia A, Inflammatory Bowel Disease

Studies at this site

• A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity — Running, not enrolling
• A Study to Learn if a Medicine Called Itraconazole Changes How the Body Processes the Study Medicine PF-08642534 in Healthy Adults. — Running, not enrolling
• Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell Disease — Completed
• A Study for Multiple Tablet Forms of The Study Medicine (PF-07220060) in Healthy Adults — Completed
• A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants. — Completed
• A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People — Completed
• A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older — Completed
• A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults — Completed
• A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants. — Completed
• A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People — Completed
• A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations. — Completed
• A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955 — Completed
• A First-in-human Study of Single Doses of PF-07328948 Which is Given to Healthy Adult Participants — Completed
• STUDY OF PF-07321332 IN HEALTHY PARTICIPANTS — Completed
• A Study to Learn About How Itraconazole Affects the Blood Level of Study Medicine (PF-07817883) in Healthy Adults. — Completed
• A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults — Completed
• Study in Healthy Adults Evaluating PF-07202954 — Completed
• Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants — Completed
• A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese — Completed
• A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults — Completed
• A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 Are Tolerated and Act in the Body in Healthy Adults — Completed
• A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants — Completed
• A Study to Understand the Effect of Low-Fat and High-Fat Meals on the Medicine Called PF-07284890 in Healthy Adults — Completed
• A Relative Bioavailability Study Evaluating Two New Encorafenib Formulations — Completed
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects. — Completed
• Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide — Completed
• Food Effect Study to Evaluate the Effect of High-Fat Meal on the Relative Bioavailability of PF-07321332 Boosted With Ritonavir in Healthy Adult Participants — Completed
• A Single Dose Study To Test Two Pediatric Forms Of Ritlecitinib Compared With Adult Ritlecitinib In Healthy Adults — Completed
• Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis — Completed
• Bioavailability Study of Naloxone 5 Milligrams (mg) Intramuscular (IM) Autoinjector — Completed
• Bioequivalence Study for Crizotinib Encapsulated Microsphere Formulation (eMS) — Completed
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy Participants — Completed
• Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy Participants — Completed
• A Study to Determine the Bioequivalence of Two Doses of Tafamidis — Completed
• Safety, Tolerability and Pharmacokinetics of BIIB118 (PF-05251749) — Completed
• Single Ascending Dose Study of Intravenous Infusion of PF 07304814 in Healthy Adult Participants — Completed
• Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease — Withdrawn before enrolling
• A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) Formulations — Completed
• A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS. — Completed
• 2-Week Study In People With Nonalcoholic Fatty Liver Disease — Completed
• A Study to Demonstrate the Equivalence of the Tofacitinib Oral Solution to the Tablet Formulation in Healthy Participants. — Completed
• Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers — Completed
• Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial Formulation — Completed
• Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Erythromelalgia — Completed
• A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy Participants — Completed
• Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements — Completed
• Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects — Completed
• A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years — Completed
• A Study To Understand Safety And Plasma Concentrations Of PF-06669571 During And Following The Oral Administration Of Single And Multiple Doses Of PF-06669571 In Healthy Volunteers Under Fasted And Fed Conditions — Completed
• Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy Subjects — Completed